NeuroSense Therapeutics (NRSN) Other Non-Current Assets (2020 - 2026)
NeuroSense Therapeutics' Other Non-Current Assets was $73,000 in Q2 2026, up 69.8% from $43,000 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Other Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at NeuroSense Therapeutics came in at $47,000, up 104.3% from FY2024.
- Other Non-Current Assets shows a three-year compound annual growth rate of 26.9% (FY2022 to FY2025).
- In earlier years, Other Non-Current Assets was $23,000 in FY2024 (+4.5%), $22,000 in FY2023 (-4.3%) and $23,000 in FY2022.
- The Q2 2026 figure marks the highest quarterly Other Non-Current Assets in data going back to Q2 2022.
- Compared with a year earlier, Other Non-Current Assets was higher in three of the last four quarters, with growth averaging 47.9%.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2025 (growth of 104.3%); the worst was Q2 2024 (a decline of 7.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | NeuroSense Therapeutics | 3.19 Mn | -1.26 Mn | - | 73,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Dec 31, 2020 | 37,000.00 |
API Access
NeuroSense Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();